Emerging STAT1 post-translational modifications: mechanisms and translational perspectives.

IF 24 1区 医学 Q1 PHARMACOLOGY & PHARMACY
Trends in pharmacological sciences Pub Date : 2026-10-01 Epub Date: 2026-09-08 DOI:10.1016/j.tips.2026.08.014
Suyeol Im, So Eun Lee, Bumseok Kim, Seung Pil Yun, Jong-Won Kim
{"title":"Emerging STAT1 post-translational modifications: mechanisms and translational perspectives.","authors":"Suyeol Im, So Eun Lee, Bumseok Kim, Seung Pil Yun, Jong-Won Kim","doi":"10.1016/j.tips.2026.08.014","DOIUrl":null,"url":null,"abstract":"<p><p>Signal transducer and activator of transcription 1 (STAT1) is a central regulator of interferon signaling, antiviral defense, inflammation, and antitumor immunity. Although STAT1 activation has been traditionally defined by phosphorylation, recent studies have revealed diverse post-translational modifications (PTMs) that fine-tune its activity, stability, localization, and transcriptional output. Newly identified modifications, including vitamin C-derived vitcylation and pyruvate-induced pyruvylation, directly link nutrient and metabolic cues to STAT1 signaling. Additional PTMs, such as acylation, glycosylation, ubiquitination, methylation, and oxidative modifications, further shape STAT1 function in a context-dependent manner. In this review, we evaluate the evidence supporting STAT1 PTMs and discuss how specific modifications regulate STAT1 activation, stability, localization, and transcriptional output in immune and inflammatory contexts, while distinguishing established regulatory mechanisms from emerging modifications that require further validation.</p>","PeriodicalId":23250,"journal":{"name":"Trends in pharmacological sciences","volume":" ","pages":"1136-1154"},"PeriodicalIF":24.0000,"publicationDate":"2026-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Trends in pharmacological sciences","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.tips.2026.08.014","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/9/8 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0

Abstract

Signal transducer and activator of transcription 1 (STAT1) is a central regulator of interferon signaling, antiviral defense, inflammation, and antitumor immunity. Although STAT1 activation has been traditionally defined by phosphorylation, recent studies have revealed diverse post-translational modifications (PTMs) that fine-tune its activity, stability, localization, and transcriptional output. Newly identified modifications, including vitamin C-derived vitcylation and pyruvate-induced pyruvylation, directly link nutrient and metabolic cues to STAT1 signaling. Additional PTMs, such as acylation, glycosylation, ubiquitination, methylation, and oxidative modifications, further shape STAT1 function in a context-dependent manner. In this review, we evaluate the evidence supporting STAT1 PTMs and discuss how specific modifications regulate STAT1 activation, stability, localization, and transcriptional output in immune and inflammatory contexts, while distinguishing established regulatory mechanisms from emerging modifications that require further validation.

新出现的STAT1翻译后修饰:机制和翻译观点。
信号转导和转录激活因子1 (STAT1)是干扰素信号、抗病毒防御、炎症和抗肿瘤免疫的中心调节因子。尽管STAT1的激活传统上被定义为磷酸化,但最近的研究表明,多种翻译后修饰(PTMs)可以微调其活性、稳定性、定位和转录输出。新发现的修饰,包括维生素c衍生的卵化和丙酮酸诱导的丙酮酰化,直接将营养和代谢线索与STAT1信号传导联系起来。其他PTMs,如酰化、糖基化、泛素化、甲基化和氧化修饰,进一步以环境依赖的方式塑造STAT1的功能。在这篇综述中,我们评估了支持STAT1 PTMs的证据,并讨论了在免疫和炎症环境下特异性修饰如何调节STAT1的激活、稳定性、定位和转录输出,同时区分了已建立的调节机制和需要进一步验证的新修饰。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
23.90
自引率
0.70%
发文量
132
审稿时长
6-12 weeks
期刊介绍: Trends in Pharmacological Sciences (TIPS) is a monthly peer-reviewed reviews journal that focuses on a wide range of topics in pharmacology, pharmacy, pharmaceutics, and toxicology. Launched in 1979, TIPS publishes concise articles discussing the latest advancements in pharmacology and therapeutics research. The journal encourages submissions that align with its core themes while also being open to articles on the biopharma regulatory landscape, science policy and regulation, and bioethics. Each issue of TIPS provides a platform for experts to share their insights and perspectives on the most exciting developments in the field. Through rigorous peer review, the journal ensures the quality and reliability of published articles. Authors are invited to contribute articles that contribute to the understanding of pharmacology and its applications in various domains. Whether it's exploring innovative drug therapies or discussing the ethical considerations of pharmaceutical research, TIPS provides a valuable resource for researchers, practitioners, and policymakers in the pharmacological sciences.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书